Kestrel

Procurement of Membrane Aerated Biofilm Reactor (MABR) systems

Severn Trent Water Limited · published Fri 6 Nov 2026

In plain English

Reading the notice and writing a summary. This takes a few seconds the first time.

Who holds it now

Last won by Scienco Limited in Jan 2026, for £1.2m.

What you're up against

  • The last two awards went to different firms: this buyer has changed supplier before.
  • 6 different firms won this buyer's 2 awards for this kind of work since 2025.
  • It last went for £1.2m in 2026.

From Severn Trent Water Limited's earlier award notices for the same kind of work. The tender documents usually say which contract this one replaces.

The documents are on portal.us.bn.cloud.ariba.com, where the bid is sent too. It's free to register there.

The notice as published

The Contracting Authority is seeking to establish a multi-supplier Framework Agreement for the provision of Membrane Aerated Biofilm Reactor (MABR) systems and associated services to support the delivery of its AMP8 Activated Sludge Plant (ASP) Intensification Programme and wider Net Zero Investment Programme. The Framework Agreement will be used to procure MABR solutions for wastewater treatment assets across the STW region and may be utilised for both current and future requirements throughout the term of the Framework. The scope of the Framework may include: - Design support; and - Manufacture and supply of MABR solutions; The current anticipated portfolio comprises approximately 11 wastewater treatment sites, however, this is indicative only. The Contracting Authority reserves the right to add, remove or amend requirements during the term of the Framework Agreement and may utilise the Framework for additional MABR opportunities associated with future AMP8 and AMP9 investment programmes. The Framework Agreement will be established for an initial term of four (4) years, with options to extend in accordance with the Framework Agreement. No guarantee of work, volume, value or future Call-Off opportunities is provided.